Physician
Tottori Allergy & Asthma Associates PC
Tottori Allergy & Asthma Associates PC was paid $7.15M by Medicaid between Jan 2018 and Dec 2024, across 20 billing codes. Its largest line is 95004, Percutaneous tests with allergenic extracts, immediate type reaction — 28% of everything it billed.
33Billing provider infoTOTTORI ALLERGY & ASTHMA ASSOCIATES PC
LAS VEGAS, NV 89104
LAS VEGAS, NV 89104
33aNPI1457384448assigned 07/10/2006
33bProvider typeAllergy & Immunology Physician
28Total paid$7.15M
24GClaims137,609
24DCodes billed20
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Nevada
Rank by total paid#1 of 9
Median peer was paid$112K
This provider vs. median64×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,370 | $204K | |
| 2019 | 22,540 | $1.15M | |
| 2020 | 19,720 | $1.03M | |
| 2021 | 24,913 | $1.34M | |
| 2022 | 22,620 | $1.30M | |
| 2023 | 24,844 | $1.21M | |
| 2024incomplete | 16,602 | $923K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 28% | 8,823 | 8,326 | $2.02M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 19% | 10,682 | 10,341 | $1.36M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 20,728 | 19,954 | $1.16M |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 15% | 4,370 | 3,354 | $1.06M |
| 95117 | 5.4% | 46,229 | 19,628 | $384K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.2% | 11,824 | 9,799 | $374K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.8% | 11,247 | 9,306 | $344K |
| 94010 | 3.0% | 8,962 | 8,110 | $215K | |
| 95024 | 1.5% | 1,192 | 1,135 | $105K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.2% | 964 | 938 | $86K |
| 96401 | <1% | 252 | 226 | $22K | |
| 95044 | <1% | 25 | 24 | $7K |
8 more codes
| 96160 | <1% | 1,868 | $6K | |
| 94060 | <1% | 125 | $5K | |
| 95115 | <1% | 398 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 127 | $1K |
| J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | <1% | 81 | $42.23 |
| J2357 | Injection, omalizumab, 5 mg | <1% | 8,519 | $28.14 |
| J3590 | Unclassified biologics | <1% | 1,167 | $3.32 |
| J0517 | Injection, benralizumab, 1 mg | <1% | 26 | $0.06 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTOTTORI, DAVID (OWNER)
Parent organizationTOTTORI ALLERGY & ASTHMA ASSOCIATES PC